Ventricular Arrhythmia With Cessation of Infliximab in a Patient With Ankylosing Spondylitis

Ventricular Arrhythmia With Cessation of Infliximab in a Patient With Ankylosing Spondylitis

Blog Article

Infliximab is an anti-tumor necrosis factor alpha agent, which is indicated for the treatment of resistant ankylosing spondylitis bostik roll-cote (AS).We presented a patient with AS who developed ventricular tachycardia after premature cessation of infliximab.Ventricular tachycardia did not recur after restarting of infliximab treatment.

This case report remarked the significance of the suppression of inflammation in AS since pentair hose the subclinical ventricular involvement may potentially lead to the fatal arrhythmias.